Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Patients should proactively disclose tirzepatide use to all healthcare providers, regardless of the clinical context
The SUSTAIN 6 cardiovascular outcomes trial demonstrated similar reductions, with participants on 0.5 mg weekly achieving a mean reduction of 1.1% (12 mmol/mol) and those on 1 mg weekly achieving 1.4% (15 mmol/mol) at 104 weeks
The formal removal from Category 2 took effect on April 23, 2026
The ceiling dose is 1.0mg daily exceeding this provides no proportional increase in melanogenesis but significantly increases off-target melanocortin receptor activation
Gut Health Support: Your gut plays a bigger role in hormone regulation than most people think
Medications like semaglutide and tirzepatide have become widely used tools in medical weight management
